Angel News


Back to Homepage

13th April 2021

Pioneering consumer drug company Maxwellia raises £3.2m from Praetura

Maxwellia, a business that is poised to transform the UK’s self-care market has secured a £3.2m investment in a funding round led by Praetura Ventures.

Maxwellia, which is based at Alderley Park in Cheshire, aims to give people easier and faster access to the treatments they need by converting prescription-only medicines to versions that can be bought in a pharmacy.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage